INCYTE

INCYTE was compromised in a ransomware attack attributed to dragonforce in April 2026. The organization, operating in the Healthcare sector in United States, was added to the group's data leak site as part of an extortion campaign.

dragonforce operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. You have been given clear instructions, reach out to us before it's too late.

Intelligence correlations link this incident to 1 vulnerability(ies) including CVE-2025-5777, which may have been leveraged as initial access vectors or for lateral movement.